Tolulope Ogriki

Tolulope Ogriki practices at Carroll Hospital in Westminster, Maryland, part of LifeBridge Health.

Tolulope Ogriki's NPI, 1174997662, was assigned on November 20, 2015. Tolulope Ogriki holds Maryland license D85077.

Tolulope Ogriki's primary practice is Carroll Hospital, at 200 Memorial Avenue, Westminster, MD 21157 in Carroll County. The practice phone is (410) 848-3000.

Tolulope Ogriki's primary practice is Carroll Hospital in Westminster, Maryland, part of LifeBridge Health. Tolulope Ogriki is also affiliated with Montefiore Einstein Hospital-Moses Campus. The medical group on file is Emergency Medicine Physicians (EMP). Dmand AI also links Tolulope Ogriki to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Tolulope Ogriki practices, 3 sites in all. Vendor and product names are available with a free account.

Hospitalist is Tolulope Ogriki's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Tolulope Ogriki is licensed in Maryland.

CMS data shows 1,734 Medicare services from Tolulope Ogriki across 6 procedure codes in 2024, for 645 Medicare patients. Medicare paid $160,210 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 645 Medicare patients who saw Tolulope Ogriki in 2024. The largest group is 75 to 84, with 232 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 19% are also on Medicaid. Their average risk score is 2.18, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Tolulope Ogriki's median patient age at 71, with 52% women.

In 2024, Tolulope Ogriki wrote 389 Medicare Part D claims for 182 patients. 91% of them were for generic drugs. CMS names the drug for 171 of them, across 9 drugs with 11 or more claims each, at $1,062 in total drug cost. In 2023, CMS named 147 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Tolulope Ogriki for performance year 2024, reported as part of a group. Tolulope Ogriki accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 14 general payments to Tolulope Ogriki from 7 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $144.